Ares Life Offers To Buy Remaining Shares Of Stallergenes For $79.90 Each

Ares Life Sciences AG plans to acquire the remaining 54.1 percent it does not already own in of allergy specialist Stallergenes for 59 euros ($79.70) a share, Reuters reported. Ares Life is a Switzerland-based health investment fund. The offer is mandatory after Ares Life bought a 45.9 percent stake of Stallergenes from Wendel Investissements SA.

DealsNorth AmericaUSBriefs